RepliCel Life Sciences's total assets for Q2 2024 were C$172.68K, a decrease of -14.74% from the previous quarter. REPCF total liabilities were C$5.15M for the fiscal quarter, a 3.31% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.